Loading...
StocksRunner logo
 
 
Alvotech
0.00%
 
ALVO Alvotech
Last Price
Change
 
0.00%
 
 
 

 
Sentiment
 
 

 
 
1m
3m
6m
1y
 

Summary

  Login to display Alvotech (ALVO) recommendation from the last 90 days from financial news and social media.
 

Strengths

Rewards

 Earnings are forecast to grow

 

Risk Analysis

Risk Analysis

 Enter oversold territory

 
 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

NA
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

2.00
 

StocksRunner

 Enter oversold territory

 

Activity

×
 

Activity

3.38
 
 

Future

×
 

Future

4.50
 

StocksRunner

 Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
64%
NA
0%
100%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
64%
27%
Positive
Negative
7 out of 11
events present
3 out of 11
events present
 

 
Events Calendar
Click for more information
 
May
S
M
T
W
T
F
S
June
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Top Headlines

alvotech: precarious cash position dilutes special situation opportunity.

Thu Jun 8, 2023

Potential

alvotech becomes oversold (alvo). legendary investor warren buffett advises to be fearful when others are greedy and be greedy when others are fearful. one way we can try to measure the level of fear in a given stock is through a technical

Tue May 23, 2023

Momentum

alvotech to participate in morgan stanley annual sustainable finance summit. reykjavik iceland may 17 2023 (globe newswire) -- alvotech (nasdaq:) a global biotech company specializing in the development and manufacture of biosimilar medicines for pat

Wed May 17, 2023

Activity

sarah tanksley joins board of directors for alvotech hf. and sandra casaca appointed chief quality officer. reykjavik iceland april 19 2023 (globe newswire) -- alvotech (nasdaq:) a global biotech company specializing in the development and manufacture

Wed Apr 19, 2023

Activity

investigation of alvotech (alvo) announced by holzer & holzer llc. ) complied with federal securities laws. on april 13 2023 alvotech disclosed that the fda issued a complete response letter (crl) for alvotech

Tue Apr 18, 2023

Activity

alvotech (alvo) declines on crl for humiras biosimilar candidate. alvotechalvo announced that it received a complete response letter (crl) from the fda for the biologics license application (bla) for avt02. the biosimilar is being deve

Fri Apr 14, 2023

Activity

relative strength alert for alvotech. legendary investor warren buffett advises to be fearful when others are greedy and be greedy when others are fearful. one way we can try to measure the level of fear in a given stock is through a techni

Fri Apr 14, 2023

Potential

mitsui acquires convertible bonds issued by alvotech and forges strategic healthcare collaboration agreement with aztiq. tokyo and london april 12 2023 (globe newswire) -- mitsui &. co. ltd. (".mitsui".) has acquired convertible bonds worth a

Wed Apr 12, 2023

Activity
Activity

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our daily ALVO alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
StocksRunner

StocksRunner

Get the pulse of the market

 
StocksRunner

ALVO Alvotech

Last Price
Change
0.00%
 
 

Most Trending

 

+4.26%

 
 
 
 

-0.83%

 
 
 

Summary

  Login to display Alvotech (ALVO) recommendation from the last 90 days from financial news and social media.

 
 
 
 
1m
3m
6m
1y
 
Sentiment

Strengths

Rewards

 Earnings are forecast to grow

Risk Analysis

Risk Analysis

 Enter oversold territory

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
NA
0%
100%
On Track
On Track
On Track
 
64%
27%
Positive
Negative
7 out of 11
events present
3 out of 11
events present
 

Street Opinion

Street view is bullish and have positive views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 

Earnings

×
 

Earnings

NA
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

2.00
 

StocksRunner

 Enter oversold territory

 

Activity

×
 

Activity

3.38
 
 

Future

×
 

Future

4.50
 

StocksRunner

 Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
 
 

Events Calendar

Hover for information

 
May
 
S
M
T
W
T
F
S
 
June
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our daily ALVO Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines